Long-term impact of a restrictive laboratory test ordering form on tumor marker prescriptions

International Journal of Technology Assessment in Health Care

Volumn 19, Issue 1, 2003, Pages 106-113

  Durieux, Pierre ^a   Ravaud, Philippe ^b   Porcher, Raphaël ^c   Fulla, Yvonne ^d   Manet, Catherine Sophie ^d   Chaussade, Stanislas ^d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c HÔpital Saint Louis ^*  (United States)

^d HÔpital Cochin ^*  (France)

Author keywords

Intervention studies; Laboratory diagnosis; Physician's practice patterns

Indexed keywords

CARBOHYDRATES; GASTROENTEROLOGY; HOSPITALS; TUMORS;

PRESCRIPTIONS;

HEALTH CARE;

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ARTICLE; COST BENEFIT ANALYSIS; COVARIANCE; GASTROINTESTINAL DISEASE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MEDICAL AUDIT; PHYSICIAN; PRESCRIPTION; PROSPECTIVE STUDY; TIME SERIES ANALYSIS; UNIVERSITY HOSPITAL;

EID: 0037412504     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462303000102     Document Type: Article

References (29)

1. American Society of Clinical Oncology. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol. 1996;14:2843-2877.
2. Avorn J, Soumerai SB, Taylor W, et al. Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med. 1988;148:1720-1724.
3. Axt-Adam P, Van der Wouden JC, Van der Does E. Influencing behavior of physicians ordering laboratory tests: A literature review. Med Care. 1993;31:784-794.
4. Bates SE. Clinical applications of serum tumor markers. Ann Intern Med. 1991;115:623-638.
5. Beilby JJ, Silagy CA. Trials of providing costing information to general practioners: A systematic review. Med J Aust. 1997;167:89-92.
6. Brook RH, McGlynn EA, Cleary PD. Quality of health care: Measuring quality of care. N Engl J Med. 1996;335:966-970.
7. Davies HT, Crombie IK. Assessing the quality of care. BMJ. 1995;311:766.
8. Duffy MJ. Ca19-9 as a marker for gastrointestinal cancers: A review. Ann Clin Biochem. 1998;35:364-370.
9. Durand-Zaleski I, Rymer JC, Roudot-Thoraval F, et al. Reducing unnecessary laboratory use with new test request form: Example of tumour markers. Lancet. 1993;342:150-153.
10. Fleiss JL. The design and analysis of clinical experiments. New York: John Wiley & Sons; 1986.
11. Gregory JJ, Finlay JL. Alpha-fetoprotein and beta-human chorionic gonadotropin: Their clinical significance as tumour markers. Drugs. 1999;57:463-467.
12. Grem J. The pronostic importance of tumor markers in adenocarcinoma of the gastrointestinal tract. Curr Opin Oncol. 1997;93:380-387.
13. Grimshaw JM, Russel IT. Effect of clinical guidelines on medical practice: Systematic review of rigourous evaluations. Lancet. 1993;342:1317-1322.
14. Grol R, Dalhuijsen J, Thomas S, et al. Attributes of clinical guidelines that influence use of guidelines in general practice: Observational study. BMJ. 1998;317:858-861.
15. Hammermeister KE. Participatory continuous improvement. Ann Thorac Surg. 1994;58:1815-1821.
16. Henderson AR. The test request form: A neglected route for communication between the physician and the clinical chemist? J Clin Pathol. 1982;35:986-998.
17. Lindblom A, Liljegren A. Tumour markers in malignancies. BMJ. 2000;320:424-427.
18. Mant JS, Hicks N. Detecting differences in quality of care: The sensitivity of measures of process and outcomes in treating acute myocardial infarction. BMJ. 1995;311:793-976.
19. NHS Centre for Reviews and Dissemination. Implementing clinical practice guidelines: Can guidelines be used to improve medical practice? Effective Health Care. 1994;8:1-12.
20. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: A systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J. 1995;153:1423-1431.
21. Ritts RE. Ca 19-9 in pancreatic cancer. Surg Oncol N Am. 1998;7:93-101.
22. Solomon DH, Hashimoto H, Daltroy L, Liang MH. Techniques to improve physicians' use of diagnostic tests. JAMA. 1998;280:2020-2027.
23. Soumerai SB, Avorn J, Taylor WC, et al. Improving choice of prescribed antibiotics through concurrent reminders in an educational order form. Med Care. 1993;31:552-558.
24. Stange KC, Kelly R, Chao S, et al. Physician agreement with US preventive service task force recommendations. J Fam Pract. 1992;34:409-416.
25. Thomson R, McElroy H, Sudlow M. Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: Variation in content and implications for treatment. BMJ. 1998;316:509-513.
26. Tierney WM, Miller ME, McDonald CJ. The effect on test ordering of informing physicians of the charges for outpatients diagnostic tests. N Engl J Med. 1990;322:1499-1504.
27. van Walraven C, Goel V, Chan B. Effect of population-based interventions on laboratory utilization. JAMA. 1998;280:2028-2033.
28. Weingarten S. Practice guidelines and prediction rules should be subject to careful clinical testing. JAMA. 1997;277:1977-1978.
29. Zaat JOM, van Euk JTM, Bonte HA. Laboratory test form design influences test ordering by general practitioners in the Netherlands. Med Care. 1992;30:189-198.